NASDAQ company ACAD who recently had their first PD drug approved, listed in 1993. No one over there is complaining as the market cap approaches $4B.
The pricing here is below the level from before the last P2 clinical trials were planned. Prana just need to get the P3 started. I am betting they can do that. I think there is plenty to support this rock bottom price, including a healthy bank.
NASDAQ company ACAD who recently had their first PD drug...
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.001(33.3%) |
Mkt cap ! $21.28M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.3¢ | $1.247K | 384.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 39 | 52935756 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 127950526 | 19 |
View Market Depth
| Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
| ATH (ASX) Chart |